Views & Analysis | Perspectives on pharma industry issues

Digital

Changing Faces: Digital and supplier hires, August 2026

Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Sales & Marketing

Wooden pawns representing number of employees

Headcount is not a growth strategy

Deciding when, where, and how quickly to add headcount is rarely straightforward.

Market Access

pharmaphorum podcast Episode 275, Giancarlo Benelli, BeOne Medicines

Europe for life sciences and for patients, with BeOne Medici...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.

R&D

Woman in black suit extends hand of welcome to the company

Changing Faces: Pharma and biotech hires, August 2026

August brought another wave of leadership changes across biotech, pharma, and research organisations.

Digital

Could #MedThreads become the new #MedTwitter?

Last month, Meta, the tech giant behind Facebook, Instagram, and WhatsApp, announced the launch of Threads: a direct challenger to its now rebranded rival, X (Twitter).

Patients

Mapping the landscape of clinical trial regulation

The COVID-19 pandemic pushed decentralised clinical trials (DCTs) into the mainstream.

Digital

Unlocking the potential of autonomous clinical research

Artificial intelligence (AI) technology has revolutionised how we approach life, work, and social interaction.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Sales & Marketing

Headcount is not a growth strategy

Deciding when, where, and how quickly to add headcount is rarely straightforward.

Digital

Changing Faces: Digital and supplier hires, August 2026

Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.

Digital

AI in clinical rials and drug development

AI in clinical trials: Building better trials before they st...

With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.

Market Access

Europe for life sciences and for patients, with BeOne Medici...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.

Market Access

Blue and white pills in pharma manufacturing line

Pharma’s most expensive question is the last one asked

Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.

Oncology

How today’s biotechs are helping us Stand Up To Cancer

In recognition of Stand Up To Cancer Day, a look at next-generation treatments that are on the verge of making it into clinical practice.

Oncology

Bridging the innovation gap: Scalable cell therapies, adapti...

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

Oncology

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

Woman in yellow jacket blows nose due to hayfever

Redefining the self-care pathway in the evolving hayfever la...

When it comes to hayfever, proactive approach improves patient health literacy and empowers individuals to put their health back in their own hands.

Patients

Pharmacist hands woman prescription medicine with an explanation

Specialty medication access hinges on a 48-hour window

The vast majority of healthcare providers (HCPs) say that PA-related delays directly harm patient outcomes.

Patients

Man lies on floor next to spilled pill bottle, reference to overdose

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

Changing Faces: Digital and supplier hires, August 2026

The patient communication crisis pharma can no longer ignore

Headcount is not a growth strategy

Europe for life sciences and for patients, with BeOne Medici...

Changing Faces: Pharma and biotech hires, August 2026

Could #MedThreads become the new #MedTwitter?

Mapping the landscape of clinical trial regulation

Unlocking the potential of autonomous clinical research

The patient communication crisis pharma can no longer ignore

Headcount is not a growth strategy

Changing Faces: Digital and supplier hires, August 2026

AI in clinical trials: Building better trials before they st...

Europe for life sciences and for patients, with BeOne Medici...

Pharma’s most expensive question is the last one asked

How today’s biotechs are helping us Stand Up To Cancer

Bridging the innovation gap: Scalable cell therapies, adapti...

Building a Phase I oncology centre

Redefining the self-care pathway in the evolving hayfever la...

Specialty medication access hinges on a 48-hour window

Decline in overdose deaths ≠ The end of the opioid crisis

Changing Faces: Pharma and biotech hires, August 2026

Trial complexity is the new normal

Mosquitoes, malaria, and UK R&D viral disease vaccine invest...

Legend Biotech names ex-Novartis exec as CEO

Discover a new era of healthcare panel engagement: Grounded ...

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks